文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review.

作者信息

Kenne Malaha Angeladine, Thébaut Clémence, Achille Dayna, Preux Pierre-Marie, Guerchet Maëlenn

机构信息

Inserm U1094, IRD UMR270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France.

Leda-Legos, PSL Research University, Paris Dauphine University, Paris, France.

出版信息

J Alzheimers Dis. 2023;91(1):115-128. doi: 10.3233/JAD-220239.


DOI:10.3233/JAD-220239
PMID:36404540
Abstract

BACKGROUND: The proportion of people living with dementia in low- and middle-income countries (LMICs) is expected to reach 71% by 2050. Appraising the economic burden of the disease may contribute to strategic policy planning. OBJECTIVE: To review studies conducted on the costs of dementia in LMICs, describe their methodology and summarize available costs estimates. METHODS: Systematic review, including a search of health, economics, and social science bibliographic databases. No date or language restrictions were applied. All studies with a direct measure of the costs of dementia care were included. RESULTS: Of the 6,843 publications reviewed, 17 studies from 11 LMICs were included. Costs of dementia tended to increase with the severity of the disease. Medical costs were greater in the mild stage, while social and informal care costs were highest in the moderate and severe stages. Annual cost estimates per patient ranged from PPP$131.0 to PPP$31,188.8 for medical costs; from PPP$16.1 to PPP$10,581.7 for social care services and from PPP$140.0 to PPP$25,798 for informal care. Overall, dementia care can cost from PPP$479.0 to PPP$66,143.6 per year for a single patient. CONCLUSION: Few studies have been conducted on the costs of dementia in LMICs, and none so far in Africa. There seems to be a need to provide accurate data on the burden of disease in these countries to guide public health policies in the coming decades.

摘要

相似文献

[1]
Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review.

J Alzheimers Dis. 2023

[2]
Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.

Pharmacoeconomics. 2021-7

[3]
The economic burden of dementia in low- and middle-income countries (LMICs): a systematic review.

BMJ Glob Health. 2022-4

[4]
The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review.

BMC Public Health. 2018-8-6

[5]
The worldwide costs of dementia in 2019.

Alzheimers Dement. 2023-7

[6]
Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates.

BMC Public Health. 2020-5-5

[7]
Societal Costs of Dementia: 204 Countries, 2000-2019.

J Alzheimers Dis. 2024

[8]
The main cost drivers in dementia: a systematic review.

Int J Geriatr Psychiatry. 2015-2

[9]
The economics of vision impairment and its leading causes: A systematic review.

EClinicalMedicine. 2022-3-22

[10]
A systematic review of the social and economic burden of influenza in low- and middle-income countries.

Vaccine. 2015-11-27

引用本文的文献

[1]
Global Societal Burden of Alzheimer's Disease by Severity: a Targeted Literature Review.

Neurol Ther. 2025-8-27

[2]
Insulin-like Growth Factor 1 Impact on Alzheimer's Disease: Role in Inflammation, Stress, and Cognition.

Curr Issues Mol Biol. 2025-3-27

[3]
Drug repurposing for Alzheimer's disease and other neurodegenerative disorders.

Nat Commun. 2025-2-19

[4]
Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections.

Open Biol. 2025-2

[5]
Effects of Yoga-Like Exercises on Mild and Moderate Alzheimer Disease: A Randomized Controlled Trial Protocol.

Tunis Med. 2025-1-5

[6]
Caregivers' experiences, challenges, and needs in caring for people with dementia in India: a scoping review.

BMC Health Serv Res. 2024-12-30

[7]
Hospital admissions for dementia in the Brazilian public health system over the last decade.

Alzheimers Dement (Amst). 2024-10-10

[8]
Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants.

Degener Neurol Neuromuscul Dis. 2024-5-19

[9]
A review of SaiLuoTong (MLC-SLT) development in vascular cognitive impairment and dementia.

Front Pharmacol. 2024-5-1

[10]
Integrative Precision Medicine for Dementia and Alzheimer's Diseases in Africa.

Aging Brain. 2023-8-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索